Compare AstraZeneca plc (AZN) vs Barrick Gold Corp (B) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Barrick Gold Corp — how do they compare? AstraZeneca plc trades at $158.42 (market cap $248.14B), while Barrick Gold Corp trades at $40.74 (market cap $65.92B). The key difference: AstraZeneca plc is far larger — about 3.8× Barrick Gold Corp's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | B | |
|---|---|---|
Market Cap | $248.14B | $65.92B |
Sector | Health | Basic Materials |
52-Week High | $209.48 | $52.97 |
52-Week Low | $147.06 | $23.50 |
Enterprise Value | $275.41B | $64.67B |
Dividend Yield | 2.01% | 1.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Barrick Gold Corp
Barrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.
Read more on B →
